Market revenue in 2022 | USD 234.3 million |
Market revenue in 2030 | USD 548.9 million |
Growth rate | 11.2% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyvinyl Chloride (PVC) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 22.28% in 2022. Horizon Databook has segmented the UK biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
The UK is one of the key consumers of biopharma plastic-based medical products in the world. Changing healthcare requirements of the masses in the country, coupled with increased spending capacities of consumers, are expected to drive the demand for biopharma plastics market in the UK over the forecast period.
Growing demand for biopharma plastics developed from polymers such as PVC, PP, PE, and ABS for manufacturing medical products such as protective wear, syringes, sensor housings, valves, and disposable connectors in the UK is expected to fuel the growth of biopharma plastics market in the country from 2022 to 2030.
Diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation among patients. According to the World Health Organization (WHO), approximately 1.5 million deaths in 2021 were estimated globally due to diabetes. Moreover, based on data provided by WHO in 2021, approximately 17.9 million deaths each year take place due to Cardiovascular Disease (CVD).
Horizon Databook provides a detailed overview of country-level data and insights on the UK biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into UK biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account